A paper published today, “Financing translation: Analysis of the NCATS rare-diseases portfolio” in Science Translational Medicine, demonstrates the potential of a new financing technique to reduce the risk associated with investing in the treatment of new diseases and po…
Source: Novel financing technique may unlock funding for developing ‘orphan’ drugs to treat rare diseases
No comments:
Post a Comment